Synta Pharmaceuticals Corp (NASDAQ:SNTA)

During the Trading Day
3.29 -0.26 / -7.32%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.29 0.00 / 0.00%
 
Volume: 18.7K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$370.5M

Company Description

Synta Pharmaceuticals Corp. discovers, develops and commercializes novel pharmaceutical products. It is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with cancer and other severe medical conditions. Its lead drug candidate, ganetespib, is a next generation Hsp90 inhibitor in Phase 3 development for non-small cell lung cancer and in a broad development program including clinical trials for breast cancer, ovarian cancer and acute myeloid leukemia. In addition, the company developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.

Contact Information

Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington Massachusetts 02421
P:(781) 274-8200
Investor Relations:

Employees

Shareholders

Individual stakeholders39.13%
Other institutional28.69%
Mutual fund holders13.91%

Top Executives

Anne C. WhitakerPresident, Chief Executive Officer & Director
Christine RedmondVice President-Operations & Program Management
Keith S. EhrlichCFO, Vice President-Finance & Administration
Vojo VukovicChief Medical Officer & Senior Vice President
Iman El-HariryVice President-Clinical Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.